Janus Henderson Group PLC Myriad Genetics Inc Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Janus Henderson Group PLC holds 39,469 shares of MYGN stock, worth $313,778. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,469
Previous 39,469
-0.0%
Holding current value
$313,778
Previous $350,000
40.29%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding MYGN
# of Institutions
234Shares Held
95.5MCall Options Held
460KPut Options Held
14.2K-
Black Rock Inc. New York, NY15.2MShares$120 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.26MShares$73.6 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.92MShares$39.2 Million0.01% of portfolio
-
State Street Corp Boston, MA4.81MShares$38.2 Million0.0% of portfolio
-
Glenview Capital Management, LLC New York, NY4.59MShares$36.5 Million0.69% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $641M
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...